Recombinant Human Erythropoietin Alfa Injection

Category: Hematopoietic growth factor / Erythropoiesis-stimulating agent
Form: Injectable solution for subcutaneous (SC) or intravenous (IV) use

Uses:

• Treatment of anemia associated with:

  • Chronic kidney disease (CKD)

  • Chemotherapy-induced anemia in cancer patients

  • Anemia due to zidovudine in HIV patients

• To reduce the need for blood transfusions in patients undergoing surgery or with chronic anemia.

Mechanism of Action:

• Recombinant erythropoietin mimics endogenous erythropoietin, a hormone produced by the kidneys.

• Stimulates red blood cell (RBC) production in the bone marrow.

• Increases hemoglobin levels and oxygen-carrying capacity of the blood.

Administration:

• Can be given subcutaneously or intravenously, depending on patient condition and clinical protocol.

• Dosage is based on body weight, hemoglobin level, and underlying condition.

• Typically administered 1–3 times per week, with adjustments based on hemoglobin response.

Side Effects:

• Cardiovascular: hypertension, increased risk of thromboembolic events.

• Hematologic: elevated hemoglobin if overdosed, which may increase clot risk.

• Flu-like symptoms: fever, headache, malaise.

• Other: injection site reactions, joint or muscle pain, rare allergic reactions.

Precautions:

• Monitor hemoglobin and hematocrit levels regularly to avoid excessive erythrocytosis.

• Use caution in patients with uncontrolled hypertension or cardiovascular disease.

• Adjust dose in patients receiving chemotherapy to avoid rapid hemoglobin increases.

• Do not use in patients with pure red cell aplasia due to anti-erythropoietin antibodies.

Summary:
Recombinant Human Erythropoietin Alfa Injection is a synthetic form of erythropoietin used to stimulate red blood cell production in anemia due to chronic kidney disease, chemotherapy, or other causes. It works by activating the bone marrow to produce more RBCs, improving oxygen delivery. Administered subcutaneously or intravenously, it requires careful monitoring of hemoglobin and blood pressure to minimize cardiovascular and thromboembolic risks.